Navigation Links
A Critical Review of Analytical Techniques for Improved Living Standards
Date:7/10/2014

Los Angeles, CA (PRWEB) July 10, 2014

OMICS Group’s 5th International conference and exhibition on Analytical and Bioanalytical techniques during 18-20 August, 2014 at Double Tree by Hilton Beijing, China is all set to critically review the recent developments in Analytical & Bioanalytical research methods only to facilitate improved living standards across the globe.

Speaking on this occasion, Dr. Srinubabu Gedela, MD of OMICS Group Inc has observed that Analytica Acta conference is a remarkable one in bringing a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and research institutions together and making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. This scientific meeting aims to serve as a catalyst for the advancement in Analytical & Bioanalytical sciences by connecting scientists within and across disciplines at conferences held under a single roof that creates an environment conducive to information exchange, generation of new ideas and acceleration of applications that benefit society.

Many eminent personalities from several top Universities and Companies along with the speakers from all over the world are going to join their peers at Analytica Acta- 2014, which includes CEOs and business people from companies like Bruker BioSpin GmbH, Merck Millipore, Abbott Nutrition R&D, Biogen Idec, Pharmaterials, Ltd, A PII Company, Fluorotronics USA, Inc., and Mintek.

Some of the prominent speakers that are going to share their expertise at this International Pharma Conference include Eduard Rogatsky, Albert Einstein College of Medicine, USA; Yuewu Xiao, Merck Millipore, USA; Farid Menaa, Fluorotronics Inc., USA; Jianping Wu, Pharmaterials, Ltd, A PII Company, UK; Qi Lin, Abbott Nutrition R&D, Singapore; Sergei Shtykov, Saratov State University, Russia; Michael Zhou, Director of Bioanalytical PR&D, Forest Laboratories, Inc., USA; Ming Li, Biogen Idec, USA; Wenxin (Shirley) Xu, Bruker BioSpin GmbH, China; Makhapa Makhafola, Mintek, South Africa; Wayne G. Carter, University of Nottingham, UK; Edward Lai, Carleton University, Canada; Erkang Wang, Chinese Academy of Sciences, China; Yuri A. Zolotov, Lomonosov Moscow University, Russia; Andrew Benniston, Newcastle University, UK; Huangxian Ju, Nanjing University, China; Hiroshi Uyama, Osaka University, Japan; Yoon-Bo Shim, Pusan National University, S. Korea; Doo Soo Chung, Seoul National University, South Korea; Susanne P Boyle, The University of Manchester, UK; Markus Link, Bruker BioSpin GmbH, Germany; L. A. Frank, Siberian Branch of the Russian Academy of Sciences, Russia; Sebania Libertino, Istituto per la Microelettronica e Microsistemi (CNR-IMM), Italy and Seung-Woo Lee, The University of Kitakyushu, Japan.

Analytica Acta- 2014 is going to discuss various important aspects of this field like Novel Approaches to Analytical and Bioanalytical Methods, Analytical Methodology, Bioanalytical Methodology, Analytical Techniques in Pharmacogenomics, NMR & Analysis of Small Organic Molecules, Advances in Chromatography and Mass Spectrometry, Analytical Techniques in Immune Chemistry, Environmental Analytical Aspects, Applications of Analytical and Bioanalytical Methods, Diagnostic Assays and Test Kits, New Instrumentation and Equipment, and Regulatory Issues and Biosafety Challenges in Bioanalysis.

For more details on Analytica Acta-2014 conference, please visit: http://www.pharmaceuticalconferences.com/analytical-bioanalytical-techniques-2014/.

While Lambda Therapeutic Research Ltd., India/UK is sponsoring Analytica Acta-2014, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), Hellenic Society of Medicinal Chemistry, (Russian) Scientific Council on Analytical Chemistry, The Chromatographic Society (CSI) of India are collaborating with OMICS Group in organising this event. OMICS Group is known for conducting International Workshops. Dr. Edward Lai from Carleton University, Canada is conducting a Symposium on "New methods for trace analysis of nanomaterials in water."

For the Tentative Program of the conference, please click here.

For further details contact
Jessie Webb
Analytica Acta-2014 Organizing Committee
Pharmaceutical Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Phone: +1-888-843-8169
Toll No +1-800-216-6499
E-mail: analytica2014(at)omicsgroup(dot)us / analytica2014(at)omicsonline(dot)us

Read the full story at http://www.prweb.com/releases/OMICS-Group-International/Analytica-Acta-2014/prweb12008798.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems
2. Alexandria Real Estate Equities, Inc. Executes 15-Year Lease Extension with NIH for 60,000 RSF of Mission-Critical Space at Alexandrias 9800 Medical Center Drive Campus in Shady Grove Life Sciences Center
3. RURO Adds Critical Level Monitoring Functionality to its Transgenic Animal Management Software ezColony
4. Knowledgent to Hold Big Data Immersion Workshop: High-impact Offering Will Provide the Answers to Today’s Critical Big Data Questions
5. Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC)
6. Marken Meets Critical Demand For In Vitro Lab Shipments
7. Critical Milestone Achieved in NaF Clincial Trials: 500+ Patients Enrolled
8. Don't Make That Critical Mistake That Rules Out Candidates From Job Interviews - Career Coach Shares Secrets to Impressive Interviewers
9. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
10. First Evidence that Adipose Stem Cell-Based Critical Limb Ischemia Treatment is Safe & Effective is published in Circulation Journal by Lead Investigator Dr. Han Cheol Lee of Pusan National University
11. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... The Energy and Resources Institute ... producing mycorrhizae. The Centre for Mycorrhizal Research at TERI ... and developed a technology that eventually produces mycorrhizae based ... ... The TERI facility has a production capacity of over ...
(Date:1/12/2017)... Pune, India , January 12, 2017 A ... by Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," projects ... from $2,921 million in 2015, growing at a CAGR of 15.07% during the forecast ... ... Allied Market Research Logo ...
(Date:1/12/2017)... Frederick, MD (PRWEB) , ... ... ... to the market’s rapid adoption of Limfinity® Cloud, RURO has enhanced the ... for cross-continent user groups, federated login, rapid data searching, and more. In ...
(Date:1/11/2017)... Angeles, California (PRWEB) , ... January 11, 2017 ... ... approach to support fertility specialists with accurate and reliable preimplantation genetic screening (PGS). ... we have achieved excellent results,” says Ovation Fertility Genetics Scientific Director Amy ...
Breaking Biology Technology:
(Date:12/8/2016)... 8, 2016 Market Research Future published a half cooked ... Mobile Biometric Security and Service Market is expected to grow over ... Market Highlights: ... Mobile Biometric Security and Service ... increasing need of authentication and security from unwanted cyber threats. The ...
(Date:12/7/2016)... BioCatch , the global leader in behavioral biometrics, reported a ... over 40 granted and pending patents. ... , The Company,s IP portfolio expansion ... Device, and Method Estimating Force Applied to a Touch Surface, " ... components needed to estimate the force and pressure applied to touch surfaces ...
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
Breaking Biology News(10 mins):